This page lists the SEC filings reported by RTW INVESTMENTS, LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-04-17 | RTW INVESTMENTS, LP | ALLURION TECHNOLOGIES, INC. | 3,936,903 | 8.1% | EDGAR |
| SC 13D/A | 2024-03-01 | RTW INVESTMENTS, LP | Avidity Biosciences, Inc. | 9,659,809 | - | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Milestone Pharmaceuticals Inc. | 3,354,825 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | AVADEL PHARMACEUTICALS PLC | 9,196,186 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Mirati Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | EXAGEN INC. | 1,504,602 | 8.8% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | PTC THERAPEUTICS, INC. | 7,423,970 | 9.8% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Axsome Therapeutics, Inc. | 4,489,596 | 9.5% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Tarsus Pharmaceuticals, Inc. | 3,152,341 | 9.5% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Tenaya Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Adicet Bio, Inc. | 4,134,631 | 9.6% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Apyx Medical Corp | 1,025,963 | 3.0% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Brainsway Ltd. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | C4 Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Celldex Therapeutics, Inc. | 3,463,201 | 6.3% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | ESTABLISHMENT LABS HOLDINGS INC. | 2,494,138 | 9.7% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Vericel Corp | 3,212,794 | 6.7% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Stoke Therapeutics, Inc. | 4,131,045 | 9.3% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Ultragenyx Pharmaceutical Inc. | 6,887,086 | 8.4% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Protagonist Therapeutics, Inc | 5,315,514 | 9.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.